ACRS R&D to Revenue
Aclaris Therapeutics Inc · R&D to Revenue
ACRS R&D to Revenue
Latest reported672.69%period ending
ACRS FY R&D/Revenue (0.00% → 672.69%)
Latest values, visible window
High-resolution chart · PNG
ACRS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 672.6936% | |
| 179.4124% | |
| 314.8389% | |
| 261.5387% | |
| 648.0254% | |
| 452.6072% | |
| 1,535.3442% | |
| 624.4079% | |
| 2,364.2305% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |